Asthma Inhaler Switch in 2024 Could Leave Some Patients Scrambling
FRIDAY, Dec. 29, 2023 (HealthDay News) — A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives. GSK, maker of the branded inhaler Flovent, will make “an authorized generic” version of the drug, but without the same branding. WhileContinue Reading